Enliven Therapeutics Insider Sold Shares Worth $345,351, According to a Recent SEC Filing
Lori Anne Kunkel, Director, on June 05, 2026, sold 10,000 shares in Enliven Therapeutics (ELVN) for $345,351. Following the Form 4 filing with the SEC, Kunkel has control over a total of 51,884 common shares of the company, with 51,884 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1672619/000153636826000004/xslF345X05/form4-06092026_080612.xml